Quest Diagnostics Incorporated · NYSE:DGX
Prevoznik Michael E sold 22,677 Quest Diagnostics Incorporated shares (Form 4)
Traded Aug 28, 2026 · Filed Aug 31, 2026
On Aug 28, 2026, Prevoznik Michael E (SVP & General Counsel) sold 22,677 Quest Diagnostics Incorporated shares at an average US$243.12 for US$5.51M under a trading plan, leaving 36,557 shares. Filed Aug 31, 2026 (Form 4).
- Sold
- 22,677 shares
- Price
- US$243.12 average (US$242.88 to US$244.51)
- Value
- US$5.51M
- Holding after
- 36,557 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- SVP & General Counsel
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 28, 2026 | Common Stock | Option exercise | 22,677 | US$112.17 | 60,234 | Direct |
| Aug 28, 2026 | Common Stock | Sale | 16,010 | US$242.88 | 44,224 | Direct |
| Aug 28, 2026 | Common Stock | Sale | 6,237 | US$243.63 | 37,987 | Direct |
| Aug 28, 2026 | Common Stock | Sale | 430 | US$244.51 | 37,557 | Direct |
| Aug 28, 2026 | Common Stock | Gift | 1,000 | 36,557 | Direct |
Source
Related
- Quest Diagnostics Incorporated
- Prevoznik Michael E
- Quest Diagnostics Incorporated shareholders
- Form 4 · Davis J. E. · Sep 3, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Aug 14, 2026
- Form 4 · Delaney Mark E · Jul 29, 2026
- Form 4 · Kuppusamy Karthik · Jul 27, 2026
- Form 4 · Carter Robert B · Jul 27, 2026